Clinical Outcomes and Complications of Basal, Bolus, and Combination Insulin Regimens in Type 2 Diabetes Mellitus: Evidence from Published Case Reports.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Clinical Outcomes and Complications of Basal, Bolus, and Combination Insulin Regimens in Type 2 Diabetes Mellitus: Evidence from Published Case Reports.
- Published In:
- Diabetes, metabolic syndrome and obesity : targets and therapy, 18, 3215-3236 (2025)
- Authors:
- Natsir, Ramdhani M, Halimah, Eli, Diantini, Ajeng, Levita, Jutti
- Database ID:
- RPEP-12737
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12737APA
Natsir, Ramdhani M; Halimah, Eli; Diantini, Ajeng; Levita, Jutti. (2025). Clinical Outcomes and Complications of Basal, Bolus, and Combination Insulin Regimens in Type 2 Diabetes Mellitus: Evidence from Published Case Reports.. Diabetes, metabolic syndrome and obesity : targets and therapy, 18, 3215-3236. https://doi.org/10.2147/DMSO.S545571
MLA
Natsir, Ramdhani M, et al. "Clinical Outcomes and Complications of Basal, Bolus, and Combination Insulin Regimens in Type 2 Diabetes Mellitus: Evidence from Published Case Reports.." Diabetes, 2025. https://doi.org/10.2147/DMSO.S545571
RethinkPeptides
RethinkPeptides Research Database. "Clinical Outcomes and Complications of Basal, Bolus, and Com..." RPEP-12737. Retrieved from https://rethinkpeptides.com/research/natsir-2025-clinical-outcomes-and-complications
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.